Emcure Of India Allies With Roche To Produce Two Biologic Cancer Drugs
This article was originally published in PharmAsia News
Executive Summary
India’s Emcure Pharmaceuticals agreed to an alliance with Roche to produce two of the Swiss drug maker’s best-selling biologic cancer drugs, Herceptin (trastuzumab) and MabThera (rituximab).